# Richtech Robotics Inc.: financial statements, quarterly

RR · Nasdaq · CIK 1963685 · [Industrials](/sectors/industrials.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/rr.md) · [Financials](/companies/rr/financials.md) · [Filings](/companies/rr/filings.md) · [Insiders](/companies/rr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5.4 d](/filings/0001213900-25-019499.md) | [1.1](/filings/0001213900-25-014251.md) | [1.2](/filings/0001213900-25-043386.md) | [1.4](/filings/0001213900-25-074423.md) | [0.5 d](/filings/0001213900-26-086751.md) | [1.3](/filings/0001213900-26-086761.md) | [1.2](/filings/0001213900-26-086762.md) | [1.2](/filings/0001213900-26-091798.md) | [1.4 d](/filings/0001213900-26-086751.md) | [1.1](/filings/0001213900-26-086761.md) | [1.5](/filings/0001213900-26-086762.md) | [1.4](/filings/0001213900-26-091798.md) |
| Cost of revenue | $m | [1.2 d](/filings/0001213900-25-019499.md) | [0.5](/filings/0001213900-25-014251.md) | [0.5](/filings/0001213900-25-043386.md) | [0.4](/filings/0001213900-25-074423.md) | [0.1 d](/filings/0001213900-26-086751.md) | [0.4](/filings/0001213900-26-086761.md) | [0.8](/filings/0001213900-26-086762.md) | [0.7](/filings/0001213900-26-091798.md) | [1.2 d](/filings/0001213900-26-086751.md) | [1.0](/filings/0001213900-26-086761.md) | [0.8](/filings/0001213900-26-086762.md) | [0.6](/filings/0001213900-26-091798.md) |
| Gross profit | $m | [4.2 d](/filings/0001213900-25-019499.md) | [0.6](/filings/0001213900-25-014251.md) | [0.7](/filings/0001213900-25-043386.md) | [1.0](/filings/0001213900-25-074423.md) | [0.4 d](/filings/0001213900-26-086751.md) | [0.8](/filings/0001213900-26-086761.md) | [0.4](/filings/0001213900-26-086762.md) | [0.4](/filings/0001213900-26-091798.md) | [0.2 d](/filings/0001213900-26-086751.md) | [0.0](/filings/0001213900-26-086761.md) | [0.7](/filings/0001213900-26-086762.md) | [0.8](/filings/0001213900-26-091798.md) |
| Research and development | $m | [0.4 d](/filings/0001213900-25-019499.md) | [0.8](/filings/0001213900-25-014251.md) | [0.4](/filings/0001213900-25-043386.md) | [0.4](/filings/0001213900-25-074423.md) | [1.0 d](/filings/0001213900-26-086751.md) | [0.5](/filings/0001213900-26-086761.md) | [0.3](/filings/0001213900-26-086762.md) | [0.5](/filings/0001213900-26-091798.md) | [2.0 d](/filings/0001213900-26-086751.md) | [1.1](/filings/0001213900-26-086761.md) | [1.1](/filings/0001213900-26-086762.md) | [1.0](/filings/0001213900-26-091798.md) |
| Operating income | $m | [2.8 d](/filings/0001213900-25-019499.md) | [(2.3)](/filings/0001213900-25-014251.md) | [(0.9)](/filings/0001213900-25-043386.md) | [(0.9)](/filings/0001213900-25-074423.md) | [(3.7) d](/filings/0001213900-26-086751.md) | [(3.9)](/filings/0001213900-26-086761.md) | [(5.1)](/filings/0001213900-26-086762.md) | [(1.8)](/filings/0001213900-26-091798.md) | [(6.4) d](/filings/0001213900-26-086751.md) | [(12.4)](/filings/0001213900-26-086761.md) | [(5.0)](/filings/0001213900-26-086762.md) | [(13.3)](/filings/0001213900-26-091798.md) |
| Interest expense | $m | not reported | [0.5](/filings/0001213900-25-014251.md) | [0.2](/filings/0001213900-25-043386.md) | [0.1](/filings/0001213900-25-074423.md) | [0.0 d](/filings/0001213900-26-086751.md) | [0.0](/filings/0001213900-26-086761.md) | [0.0](/filings/0001213900-26-086762.md) | [0.0](/filings/0001213900-26-091798.md) | [0.1 d](/filings/0001213900-26-086751.md) | [0.0](/filings/0001213900-26-086761.md) | [0.0](/filings/0001213900-26-086762.md) | [0.0](/filings/0001213900-26-091798.md) |
| Income tax | $m | not reported | not reported | not reported | [0.3](/filings/0001213900-25-074423.md) | [0.1 d](/filings/0001213900-26-086751.md) | not reported | not reported | [0.0](/filings/0001213900-26-091798.md) | [(0.1) d](/filings/0001213900-26-086751.md) | not reported | not reported | not reported |
| Net income | $m | [2.2 d](/filings/0001213900-25-019499.md) | [(2.7)](/filings/0001213900-25-014251.md) | [(1.1)](/filings/0001213900-25-043386.md) | [(1.3)](/filings/0001213900-25-074423.md) | [(3.5)](/filings/0001213900-26-015097.md) | [(29.5)](/filings/0001213900-26-086761.md) | [(0.6)](/filings/0001213900-26-086762.md) | [(1.7)](/filings/0001213900-26-091798.md) | [(8.4)](/filings/0001213900-26-015097.md) | [(10.1)](/filings/0001213900-26-086761.md) | [(0.3)](/filings/0001213900-26-086762.md) | [(10.0)](/filings/0001213900-26-091798.md) |
| Diluted EPS | $ per share | not reported | [(0.04)](/filings/0001213900-25-014251.md) | [(0.02)](/filings/0001213900-25-043386.md) | [(0.02)](/filings/0001213900-25-074423.md) | [(0.04)](/filings/0001213900-26-015097.md) | [(0.31)](/filings/0001213900-26-086761.md) | [0.00](/filings/0001213900-26-086762.md) | [(0.01)](/filings/0001213900-26-091798.md) | [(0.04)](/filings/0001213900-26-015097.md) | [(0.05)](/filings/0001213900-26-086761.md) | [0.00](/filings/0001213900-26-086762.md) | [(0.04)](/filings/0001213900-26-091798.md) |
| Basic EPS | $ per share | not reported | [(0.04)](/filings/0001213900-25-014251.md) | [(0.02)](/filings/0001213900-25-043386.md) | [(0.02)](/filings/0001213900-25-074423.md) | [(0.04)](/filings/0001213900-26-015097.md) | [(0.31)](/filings/0001213900-26-086761.md) | [0.00](/filings/0001213900-26-086762.md) | [(0.01)](/filings/0001213900-26-091798.md) | [(0.04)](/filings/0001213900-26-015097.md) | [(0.05)](/filings/0001213900-26-086761.md) | [0.00](/filings/0001213900-26-086762.md) | [(0.04)](/filings/0001213900-26-091798.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.4](/filings/0001213900-25-019499.md) | [7.5](/filings/0001213900-24-014132.md) | [8.2](/filings/0001213900-24-043063.md) | [9.2](/filings/0001213900-24-069231.md) | [14.6](/filings/0001213900-26-086751.md) | [19.8](/filings/0001213900-25-014251.md) | [11.1](/filings/0001213900-25-043386.md) | [32.9](/filings/0001213900-25-074423.md) | [186](/filings/0001213900-26-086761.md) | [138](/filings/0001213900-26-086761.md) | not reported | not reported |
| Current assets | $m | [7.0](/filings/0001213900-25-019499.md) | [11.5](/filings/0001213900-24-014132.md) | [12.4](/filings/0001213900-24-043063.md) | [12.7](/filings/0001213900-24-069231.md) | [32.9](/filings/0001213900-26-086751.md) | [39.3](/filings/0001213900-26-086751.md) | [44.9](/filings/0001213900-26-086751.md) | [88.6](/filings/0001213900-26-086751.md) | [255](/filings/0001213900-26-091798.md) | [332](/filings/0001213900-26-086761.md) | [366](/filings/0001213900-26-086762.md) | [345](/filings/0001213900-26-091798.md) |
| Total assets | $m | [7.9](/filings/0001213900-25-019499.md) | [12.3](/filings/0001213900-24-014132.md) | [13.2](/filings/0001213900-24-043063.md) | [13.4](/filings/0001213900-24-069231.md) | [42.6](/filings/0001213900-26-086751.md) | [52.9](/filings/0001213900-26-086751.md) | [58.6](/filings/0001213900-26-086751.md) | [106](/filings/0001213900-26-086751.md) | [274](/filings/0001213900-26-091798.md) | [350](/filings/0001213900-26-086761.md) | [383](/filings/0001213900-26-086762.md) | [373](/filings/0001213900-26-091798.md) |
| Current liabilities | $m | [2.9](/filings/0001213900-25-019499.md) | [0.8](/filings/0001213900-24-014132.md) | [2.9](/filings/0001213900-24-043063.md) | [3.9](/filings/0001213900-24-069231.md) | [7.4](/filings/0001213900-26-086751.md) | [21.6](/filings/0001213900-26-086751.md) | [7.7](/filings/0001213900-26-086751.md) | [8.1](/filings/0001213900-26-086751.md) | [21.7](/filings/0001213900-26-091798.md) | [6.9](/filings/0001213900-26-086761.md) | [4.0](/filings/0001213900-26-086762.md) | [3.7](/filings/0001213900-26-091798.md) |
| Total liabilities | $m | [3.0](/filings/0001213900-25-019499.md) | [1.0](/filings/0001213900-24-014132.md) | [3.0](/filings/0001213900-24-043063.md) | [4.3](/filings/0001213900-24-069231.md) | [8.0](/filings/0001213900-26-086751.md) | [22.2](/filings/0001213900-26-086751.md) | [8.5](/filings/0001213900-26-086751.md) | [8.9](/filings/0001213900-26-086751.md) | [22.2](/filings/0001213900-26-091798.md) | [7.4](/filings/0001213900-26-086761.md) | [4.6](/filings/0001213900-26-086762.md) | [4.1](/filings/0001213900-26-091798.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.1](/filings/0001213900-26-091798.md) | [0.1](/filings/0001213900-26-086761.md) | [0.1](/filings/0001213900-26-086762.md) | [0.1](/filings/0001213900-26-091798.md) |
| Short-term borrowings | $m | [0.8](/filings/0001213900-25-019499.md) | [0.1](/filings/0001213900-24-014132.md) | [2.1](/filings/0001213900-24-043063.md) | [2.4](/filings/0001213900-24-069231.md) | [0.1](/filings/0001213900-26-086751.md) | [0.1](/filings/0001213900-25-014251.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [4.8](/filings/0001213900-25-019499.md) | [11.3](/filings/0001213900-24-043063.md) | [10.2](/filings/0001213900-24-069231.md) | [9.1](/filings/0001213900-24-069231.md) | [33.9](/filings/0001213900-26-086751.md) | [29.9](/filings/0001213900-26-086751.md) | [49.1](/filings/0001213900-26-086751.md) | [96.5](/filings/0001213900-26-086751.md) | [251](/filings/0001213900-26-091798.md) | [340](/filings/0001213900-26-015097.md) | [379](/filings/0001213900-26-086762.md) | [369](/filings/0001213900-26-091798.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(0.6) d](/filings/0001213900-25-019499.md) | [(1.2)](/filings/0001213900-25-014251.md) | [(1.3) d](/filings/0001213900-25-043386.md) | [0.4 d](/filings/0001213900-25-074423.md) | [(2.8) d](/filings/0001213900-26-086751.md) | [(2.4)](/filings/0001213900-26-086761.md) | [(2.6) d](/filings/0001213900-26-086762.md) | [(0.5) d](/filings/0001213900-26-091798.md) | [(3.5) d](/filings/0001213900-26-086751.md) | [(1.6)](/filings/0001213900-26-086761.md) | [(0.4) d](/filings/0001213900-26-086762.md) | [(1.5) d](/filings/0001213900-26-091798.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | [0.1](/filings/0001213900-26-086761.md) | [0.2 d](/filings/0001213900-26-086762.md) | [4.5 d](/filings/0001213900-26-091798.md) | [0.3 d](/filings/0001213900-26-086751.md) | [0.1](/filings/0001213900-26-086761.md) | [0.2 d](/filings/0001213900-26-086762.md) | [21.4 d](/filings/0001213900-26-091798.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2022-12-31) | period not labelled (2023-03-31) | period not labelled (2023-06-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [62.0](/filings/0001213900-24-014132.md) | [62.0](/filings/0001213900-24-043063.md) | [62.1](/filings/0001213900-24-069231.md) | [64.3](/filings/0001213900-25-014251.md) | [66.6](/filings/0001213900-24-043063.md) | [69.7](/filings/0001213900-24-069231.md) | [95.8](/filings/0001213900-26-086761.md) | [113](/filings/0001213900-26-086762.md) | [120](/filings/0001213900-26-091798.md) | [198](/filings/0001213900-26-086761.md) | [221](/filings/0001213900-26-086762.md) | [224](/filings/0001213900-26-091798.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 21,288,410 at 2024-02-14, from the cover of the [10-Q filed 2024-02-14](/filings/0001213900-24-014132.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.